Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129674) titled 'The application of serum EDA2R in the detection of neurosyphilis' on Aug. 7.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Beijing Ditan Hospital, Capital Medical University
Condition:
neurosyphilis
Intervention:
Gold Standard:Direct microscopic examination of Treponema pallidum
detection of specific antibodies and non-specific antibodies of Treponema pallidum in serum
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-08-20
Target Sample Size: Target condition:100;Difficult condition:0
Countries of Recruitment:
China
To know more, v...